PT  - JOURNAL ARTICLE
AU  - Kang Zhao
AU  - Jucun Huang
AU  - Dan Dai
AU  - Yuwei Feng
AU  - Liming Liu
AU  - Shuke Nie
TI  - Acute myelitis after SARS-CoV-2 infection: a case report
AID  - 10.1101/2020.03.16.20035105
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.16.20035105
4099  - http://medrxiv.org/content/early/2020/04/09/2020.03.16.20035105.short
4100  - http://medrxiv.org/content/early/2020/04/09/2020.03.16.20035105.full
AB  - We report a case of acute myelitis in a patient infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A 66-year-old man with coronavirus disease 2019 was admitted with acute flaccid paralysis of the bilateral lower limbs and urinary and bowel incontinence. All serum microbiological test results were negative, except for SARS-CoV-2 nucleic acid testing. Clinical findings indicated post-infectious acute myelitis. He received treatment containing ganciclovir, lopinavir/ritonavir, moxifloxacin, dexamethasone, human immunoglobulin, and mecobalamin. With a diagnosis of post-infectious acute myelitis and comprehensive treatment, paralysis of the bilateral lower extremities ameliorated. After two negative novel coronavirus RNA nasopharyngeal swab tests, he was discharged and transferred to a designated hospital for isolation and rehabilitation therapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the second medical and health youth top talent project of Hubei Province (2019).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo datasets were generated or analyzed for this study.